Literature DB >> 35538180

Positional obstructive sleep apnea in patients with atrial fibrillation.

Patrick L Stafford1, Evan Harmon2, Paras Patel3, McCall Walker4, Nazem Akoum5, Seung-Jung Park6, Yeilim Cho5, Kenneth Bilchick3, Nishaki Mehta7, Sula Mazimba3, Yoonsik Cho8, Younghoon Kwon5.   

Abstract

PURPOSE: Obstructive sleep apnea (OSA) is a common, potentially modifiable condition implicated in the pathogenesis of atrial fibrillation (AF). The presence and severity of OSA is largely sleep position-dependent, yet there is high variability in positional dependence among patients with OSA. We investigated the prevalence of positional OSA (POSA) and examined associated factors in patients with AF.
METHODS: We recruited an equal number of patients with and without AF who underwent diagnostic polysomnography. Patients included had ≥ 120 min of total sleep time with 30 min of sleep in both supine and lateral positions. POSA was defined as an overall apnea hypopnea index (AHI) ≥ 5/h, supine AHI (sAHI) ≥ 5/h, and sAHI greater than twice the non-supine AHI. POSA prevalence was compared in patients with and without AF adjusting for age, sex, OSA severity, and heart failure.
RESULTS: A total of patients (male: 56%, mean age 62 years) were included. POSA prevalence was similar between the two groups (46% vs. 39%; p = 0.33). Obesity and severe OSA (AHI ≥ 30/h) were associated with low likelihood of POSA (OR [CI] of 0.17 [0.09-0.32] and 0.28 [0.12-0.62]). In patients with AF, male sex was associated with a higher likelihood of POSA (OR [CI] of 3.16 [1.06-10.4]).
CONCLUSION: POSA is common, affecting more than half of patients with AF, but the prevalence was similar in those without AF. Obesity and more severe OSA are associated with lower odds of POSA. Positional therapy should be considered in patients with mild OSA and POSA.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Atrial fibrillation; Obstructive sleep apnea; Positional sleep apnea

Year:  2022        PMID: 35538180     DOI: 10.1007/s11325-022-02625-y

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  26 in total

1.  Prevalence and physiological predictors of sleep apnea in patients with heart failure and systolic dysfunction.

Authors:  Dai Yumino; Hanqiao Wang; John S Floras; Gary E Newton; Susanna Mak; Pimon Ruttanaumpawan; John D Parker; T Douglas Bradley
Journal:  J Card Fail       Date:  2009-01-21       Impact factor: 5.712

2.  Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea: the impact of continuous positive airway pressure.

Authors:  Dimpi Patel; Prasant Mohanty; Luigi Di Biase; Mazen Shaheen; William R Lewis; Kara Quan; Jennifer E Cummings; Paul Wang; Amin Al-Ahmad; Preeti Venkatraman; Eyad Nashawati; Dhanunjaya Lakkireddy; Robert Schweikert; Rodney Horton; Javier Sanchez; Joseph Gallinghouse; Steven Hao; Salwa Beheiry; Deb S Cardinal; Jason Zagrodzky; Robert Canby; Shane Bailey; J David Burkhardt; Andrea Natale
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-08-05

3.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  J Arrhythm       Date:  2017-09-15

4.  Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients.

Authors:  Olaf Oldenburg; Barbara Lamp; Lothar Faber; Helmut Teschler; Dieter Horstkotte; Volker Töpfer
Journal:  Eur J Heart Fail       Date:  2006-10-05       Impact factor: 15.534

5.  Relation of the severity of obstructive sleep apnea in response to anti-arrhythmic drugs in patients with atrial fibrillation or atrial flutter.

Authors:  Ken Monahan; Jordan Brewster; Li Wang; Babar Parvez; Sandeep Goyal; Dan M Roden; Dawood Darbar
Journal:  Am J Cardiol       Date:  2012-04-18       Impact factor: 2.778

6.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

7.  Coronary heart disease incidence in sleep disordered breathing: the Wisconsin Sleep Cohort Study.

Authors:  Khin Mae Hla; Terry Young; Erika W Hagen; James H Stein; Laurel A Finn; F Javier Nieto; Paul E Peppard
Journal:  Sleep       Date:  2015-05-01       Impact factor: 5.849

8.  Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure.

Authors:  Katherine Ferrier; Angela Campbell; Brendon Yee; Mark Richards; Tim O'Meeghan; Mark Weatherall; Alister Neill
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

Review 9.  Sleep, sleep apnea and atrial fibrillation: Questions and answers.

Authors:  Younghoon Kwon; Ryan J Koene; Alan R Johnson; Gen-Min Lin; John D Ferguson
Journal:  Sleep Med Rev       Date:  2017-09-04       Impact factor: 11.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.